High quality iPSC-derived human cells for drug discovery and cell-based therapies
TrailBio® Hematopoietic Progenitor Cells
Our TrailBio® Hematopoietic Progenitor Cells (HPCs) are suitable for differentiation into multiple blood lineages, including erythroid and myeloid pathways, making them ideal for applications such as disease modeling, drug discovery and toxicology studies.
TrailBio® Vascular Leptomeningeal Cells
Our TrailBio® Vascular Leptomeningeal Cells (VLMCs) are iPSC-derived fibroblast-like cells that form a critical component of the blood-brain barrier. Developed using our proprietary HD-DoE® platform, these neuroectoderm-derived cells line blood vessels in the subarachnoid space alongside pericytes, expressing specific markers that confirm their unique identity and function—ideal for blood-brain barrier interface studies.
Powered by HD-DoE®
Pioneering Precision in Cellular Differentiation
Trailhead Biosystems® utilizes the High-Dimensional Design-of-Experiments (HD-DoE®) platform to revolutionize cellular research. This advanced method allows us to efficiently explore and optimize cell growth and differentiation processes. By analyzing multiple variables together, HD-DoE accelerates our development of precise cellular therapies and products. It’s a cornerstone of our approach to advancing regenerative medicine and personalized healthcare, enabling us to make significant breakthroughs in biotechnology.
We're Hiring!
If you want to make a difference in the life sciences, you have come to the right place! As a rapidly expanding and evolving biotech company, we are seeking individuals who are highly adaptable, possess unwavering integrity, and have ambitious career goals. If that sounds like you, follow the link below to become a Trailblazer!
